University of Kansas Cancer Center

Add to Favorites Newsroom RSS Share

fb-shareUniversity of Kansas Cancer Center

twitter-shareUniversity of Kansas Cancer Center

Kansas City, KS USA

Our News on Newswise
View All >

Researcher Identifies Four Hallmarks of Metastasis

A literature review seeks to summarize the metastatic research landscape and identify the distinguishing features of metastasis. This is the first paper that attempts to define the process in terms of core hallmarks.
3-May-2019 9:00 AM EDT Add to Favorites

NIH Awards $11.4 Million to Establish Kansas Institute for Precision Medicine at KU Medical Center

A team led by Andrew Godwin, PhD, deputy director of The University of Kansas Cancer Center and director of molecular oncology in the department of Pathology and Laboratory Medicine, has been awarded a five-year, $11.4 million National Institutes of...
21-Mar-2019 2:05 PM EDT Add to Favorites

The University of Kansas Cancer Center Joins The Leukemia & Lymphoma Society’s Innovative Clinical Trial

The University of Kansas Cancer Center is one of the latest major cancer research institutions to join The Leukemia & Lymphoma Society’s (LLS) Beat AML Master Clinical Trial, a paradigm-shifting collaboration to bring precision medicine to...
12-Mar-2019 10:05 AM EDT Add to Favorites

Researchers Identify New Target for Treatment of Pancreatic Cancer

A preclinical study has identified a region of the human genome, called a super-enhancer, as a novel target for a pancreatic cancer subtype.
6-Mar-2019 10:35 AM EST Add to Favorites

Partnership Program Extends Reach of Clinical Trials

A new, first-of-its kind project from researchers at The University of Kansas Cancer Center aims to boost participation in urologic cancer clinical trials by partnering with community urologists.
6-Mar-2019 9:05 AM EST Add to Favorites

Examining the "Forgotten Organ"

KU Cancer Center researcher Shahid Umar, PhD, is examining the microbiome's connection to colorectal cancer.
6-Mar-2019 9:00 AM EST Add to Favorites

Breakthrough 'Lab-on-a-Chip' Detects Cancer Faster, Cheaper and Less Invasively

A new ultrasensitive diagnostic device invented by researchers at the University of Kansas, The University of Kansas Cancer Center and KU Medical Center could allow doctors to detect cancer quickly from a droplet of blood or plasma, leading to...
22-Feb-2019 4:35 PM EST Add to Favorites

Newswise: TumorinaDishClose-upcropped.jpg

Mimicking Metastasis in a Dish

Researchers at The University of Kansas Cancer Center have developed a first-of-its-kind organoid that mirrors the process of cancer spreading to the lung.
18-Feb-2019 12:05 PM EST Add to Favorites

see all news

Our Experts on Newswise

VIDEO

Triple-Threat

Triple-negative breast cancer expert Dr. Priyanka Sharma discusses latest research and clinical trial efforts.
18-Jul-2018 1:35 PM EDT

Getting Survivorship Care Planning Off the Page and Into Practice

Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT

Rewriting the Book on Chemo-Resistant Cancers with a DNA Library

KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT

see all experts

Our YouTube Videos
View All >

About

The University of Kansas Cancer Center is a world-class, community-based, NCI-designated cancer research and care partnership spanning two states and involving collaboration among researchers, physicians and cancer support professionals. Together, we are working toward a world without cancer. The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program. Our partnership includes cancer research and health care professionals associated with the University of Kansas Medical Center and The University of Kansas Hospital in Kansas City, The University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, The Stowers Institute for Medical Research and the members of the Midwest Cancer Alliance. Our research programs include Cancer Biology, Cancer Prevention, Cancer Control and Population Health, and Drug Discovery, Delivery and Experimental Therapeutics. Shared resources include Biospecimen, Biostatistics and Informatics, Clinical Research Office and Lead Development and Optimization.

Disease-specific working groups, including both clinicians and basic research investigators, promote collaborative opportunities and the exchange of research ideas. The disease working groups define clinical research priorities respective to their disease specialty with an emphasis on Investigator Initiated Trials (IITs). The cancer center’s current disease working groups include lung, hematology/bone marrow transplant, gastrointestinal, genitor-urinary, head and neck, breast and brain.

Breaking new ground in cancer research requires state-of-the-art facilities. A 82,400-square-foot University of Kansas Clinical Research Center, which opened in January 2012, houses the Phase I clinical trials program. A recently remodeled, 170,000-square-foot Wahl/Hixon research complex, known as The Kansas Masonic Cancer Research Institute, will house 37 cancer-focused researchers. Building a world-class cancer center that is at the forefront of discovery, development and implementation is just the beginning. The legacy of The University of Kansas Cancer Center endures when discoveries made here benefit cancer patients everywhere.

Contacts

Kay Hawes Assoc. Dir of News & Media Relations Health Care		913-617-8698
Pauline Horton Communications Specialist		913-945-6896
Natalie Lutz Executive Director, Marketing & University Relatio		913-588-2598
Donna Peck Assistant Communications Director		913-588-5956
Christine Wilson Director of Public Relations		913-945-6017